MR-imaging to diagnose endometriosis using Ablavar ® as contrast agent – a feasibility study’

未提供0 个研究点开始时间: 2012年10月19日最近更新: 2013年4月15日

适应症

试验速览

暂无简介。

•18 years and older;
•Suspicion of peritoneal endometriosis, palpable nodule located at the sacrouterine ligaments at physical examination;
•Patient planned for MRI and laparoscopic diagnosis and treatment of the disease (care as usual);
•Pre menopausal;
•Using contraception during the time of the study;
•Willing and able to undergo all study procedures;
•Written informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 5
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Pregnancy / breast feeding;
•Post menopausal or under GnRH analogue treatment;
•Patients presenting with a contraindication to MRI such as pacemaker, aneurysm clip, severe claustrophobia or ferromagnetic implants;
•Impaired kidney function or acute kidney injury;
•History of severe allergic reaction or allergic reaction to MR contrast media;
•Allergy (hypersensitivity) to any of the ingredients of Ablavar ®;
•Being unable to give informed consent in person.

发起方

未提供